REFERENCES
R. L. Siegel, K. D. Miller, H. E. Fuchs,A. Jemal, Cancer Statistics, 2021. (2021).CA Cancer J Clin,1, 7-33.http://dx.doi.org/10.3322/caac.21654
M. S. Litwin,H. J. Tan, The Diagnosis and Treatment of Prostate Cancer: A Review. (2017).Jama,24, 2532-2542.http://dx.doi.org/10.1001/jama.2017.7248
P. A. Watson, V. K. Arora,C. L. Sawyers, Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. (2015).Nat Rev Cancer,12, 701-11.http://dx.doi.org/10.1038/nrc4016
R. Gao, D. K. Price, W. L. Dahut, E. Reed,W. D. Figg, Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. (2010).Cancer Biol Ther,1, 13-8.http://dx.doi.org/10.4161/cbt.10.1.12172
K. Ruggero, S. Farran-Matas, A. Martinez-Tebar,A. Aytes, Epigenetic Regulation in Prostate Cancer Progression. (2018).Curr Mol Biol Rep,2, 101-115.http://dx.doi.org/10.1007/s40610-018-0095-9
K. Arita, S. Isogai, T. Oda, M. Unoki, K. Sugita, N. Sekiyama, K. Kuwata, R. Hamamoto, H. Tochio, M. Sato, M. Ariyoshi,M. Shirakawa, Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1. (2012).Proc Natl Acad Sci U S A,32, 12950-5.http://dx.doi.org/10.1073/pnas.1203701109
S. A. Bert, M. D. Robinson, D. Strbenac, A. L. Statham, J. Z. Song, T. Hulf, R. L. Sutherland, M. W. Coolen, C. Stirzaker,S. J. Clark, Regional activation of the cancer genome by long-range epigenetic remodeling. (2013).Cancer Cell,1, 9-22.http://dx.doi.org/10.1016/j.ccr.2012.11.006
D. Patnaik, P. O. Estève,S. Pradhan, Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development. (2018).Oncotarget,40, 26243-26258.http://dx.doi.org/10.18632/oncotarget.25425
J. Yang, K. Liu, J. Yang, B. Jin, H. Chen, X. Zhan, Z. Li, L. Wang, X. Shen, M. Li, W. Yu,Z. Mao, PIM1 induces cellular senescence through phosphorylation of UHRF1 at Ser311. (2017).Oncogene,34, 4828-4842.http://dx.doi.org/10.1038/onc.2017.96
H. Chen, H. Ma, H. Inuzuka, J. Diao, F. Lan, Y. G. Shi, W. Wei,Y. Shi, DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase. (2013).Mol Cell Biol,6, 1139-48.http://dx.doi.org/10.1128/mcb.01191-12
A. Beck, F. Trippel, A. Wagner, S. Joppien, M. Felle, C. Vokuhl, T. Schwarzmayr, T. M. Strom, D. von Schweinitz, G. Langst,R. Kappler, Overexpression of UHRF1 promotes silencing of tumor suppressor genes and predicts outcome in hepatoblastoma. (2018).Clin Epigenetics,27.http://dx.doi.org/10.1186/s13148-018-0462-7
H. J. Jung, H. O. Byun, B. A. Jee, S. Min, U. W. Jeoun, Y. K. Lee, Y. Seo, H. G. Woo,G. Yoon, The Ubiquitin-like with PHD and Ring Finger Domains 1 (UHRF1)/DNA Methyltransferase 1 (DNMT1) Axis Is a Primary Regulator of Cell Senescence. (2017).J Biol Chem,9, 3729-3739.http://dx.doi.org/10.1074/jbc.M116.750539
P. A. Pérez-Mancera, A. R. Young,M. Narita, Inside and out: the activities of senescence in cancer. (2014).Nat Rev Cancer,8, 547-58.http://dx.doi.org/10.1038/nrc3773
X. L. Su, J. W. Wang, H. Che, C. F. Wang, H. Jiang, X. Lei, W. Zhao, H. X. Kuang,Q. H. Wang, Clinical application and mechanism of traditional Chinese medicine in treatment of lung cancer. (2020).Chin Med J (Engl),24, 2987-2997.http://dx.doi.org/10.1097/CM9.0000000000001141
M. J. Hsieh, M. K. Chen, Y. Y. Yu, G. T. Sheu,H. L. Chiou, Psoralen reverses docetaxel-induced multidrug resistance in A549/D16 human lung cancer cells lines. (2014).Phytomedicine,7, 970-7.http://dx.doi.org/10.1016/j.phymed.2014.03.008
L. Zhang, B. Yan, S. Meng, L. Zhou, Y. Xu, W. Du,L. Shan, Theaflavin Induces Apoptosis of A375 Human Melanoma Cells and Inhibits Tumor Growth in Xenograft Zebrafishes Through P53- and JNK-Related Mechanism. (2020).Front Pharmacol,1317.http://dx.doi.org/10.3389/fphar.2020.01317
P. Duan,Z. M. Wang, [Clinical study on effect of Astragalus in efficacy enhancing and toxicity reducing of chemotherapy in patients of malignant tumor]. (2002).Zhongguo Zhong Xi Yi Jie He Za Zhi,7, 515-7.http://dx.doi.org/
Y. Zhang, Z. Wu, H. Yu, H. Wang, G. Liu, S. Wang,X. Ji, Chinese Herbal Medicine Wenxia Changfu Formula Reverses Cell Adhesion-Mediated Drug Resistance via the Integrin beta1-PI3K-AKT Pathway in Lung Cancer. (2019).J Cancer,2, 293-304.http://dx.doi.org/10.7150/jca.25163
D. H. J. Cheong, D. W. S. Tan, F. W. S. Wong,T. Tran, Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. (2020).Pharmacol Res,104901.http://dx.doi.org/10.1016/j.phrs.2020.104901
H. S. Kim, E. H. Lee, S. R. Ko, K. J. Choi, J. H. Park,D. S. Im, Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. (2004).Arch Pharm Res,4, 429-35.http://dx.doi.org/10.1007/bf02980085
H. Wang, Y. Zheng, Q. Sun, Z. Zhang, M. Zhao, C. Peng,S. Shi, Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. (2021).J Nanobiotechnology,1, 322.http://dx.doi.org/10.1186/s12951-021-01062-5
D. Zhang, Y. Chu, H. Qian, L. Qian, J. Shao, Q. Xu, L. Yu, R. Li, Q. Zhang, F. Wu, B. Liu,Q. Liu, Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer. (2020).Int J Nanomedicine,735-747.http://dx.doi.org/10.2147/IJN.S231448
D. J. Newman,G. M. Cragg, Natural Products as Sources of New Drugs from 1981 to 2014. (2016).J Nat Prod,3, 629-61.http://dx.doi.org/10.1021/acs.jnatprod.5b01055
M. Krifa, L. Leloup, K. Ghedira, M. Mousli,L. Chekir-Ghedira, Luteolin induces apoptosis in BE colorectal cancer cells by downregulating calpain, UHRF1, and DNMT1 expressions. (2014).Nutr Cancer,7, 1220-7.http://dx.doi.org/10.1080/01635581.2014.951729
M. Achour, M. Mousli, M. Alhosin, A. Ibrahim, J. Peluso, C. D. Muller, V. B. Schini-Kerth, A. Hamiche, S. Dhe-Paganon,C. Bronner, Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. (2013).Biochem Biophys Res Commun,1, 208-12.http://dx.doi.org/10.1016/j.bbrc.2012.11.087
M. Alhosin, A. Abusnina, M. Achour, T. Sharif, C. Muller, J. Peluso, T. Chataigneau, C. Lugnier, V. B. Schini-Kerth, C. Bronner,G. Fuhrmann, Induction of apoptosis by thymoquinone in lymphoblastic leukemia Jurkat cells is mediated by a p73-dependent pathway which targets the epigenetic integrator UHRF1. (2010).Biochem Pharmacol,9, 1251-60.http://dx.doi.org/10.1016/j.bcp.2009.12.015
M. Krifa, M. Alhosin, C. D. Muller, J. P. Gies, L. Chekir-Ghedira, K. Ghedira, Y. Mély, C. Bronner,M. Mousli, Limoniastrum guyonianum aqueous gall extract induces apoptosis in human cervical cancer cells involving p16 INK4A re-expression related to UHRF1 and DNMT1 down-regulation. (2013).J Exp Clin Cancer Res,1, 30.http://dx.doi.org/10.1186/1756-9966-32-30
T. Sharif, C. Auger, M. Alhosin, C. Ebel, M. Achour, N. Etienne-Selloum, G. Fuhrmann, C. Bronner,V. B. Schini-Kerth, Red wine polyphenols cause growth inhibition and apoptosis in acute lymphoblastic leukaemia cells by inducing a redox-sensitive up-regulation of p73 and down-regulation of UHRF1. (2010).Eur J Cancer,5, 983-94.http://dx.doi.org/10.1016/j.ejca.2009.12.029
M. Alhosin, A. J. León-González, I. Dandache, A. Lelay, S. K. Rashid, C. Kevers, J. Pincemail, L. M. Fornecker, L. Mauvieux, R. Herbrecht,V. B. Schini-Kerth, Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway. (2015).Sci Rep,8996.http://dx.doi.org/10.1038/srep08996
M. Chow, L. Gao, J. D. MacManiman, V. T. Bicocca, B. H. Chang, J. J. Alumkal,J. W. Tyner, Maintenance and pharmacologic targeting of ROR1 protein levels via UHRF1 in t(1;19) pre-B-ALL. (2018).Oncogene,38, 5221-5232.http://dx.doi.org/10.1038/s41388-018-0299-8
J. S. Seo, Y. H. Choi, J. W. Moon, H. S. Kim,S. H. Park, Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells. (2017).BMC Cell Biol,1, 14.http://dx.doi.org/10.1186/s12860-017-0130-3
Z. Tang, C. Li, B. Kang, G. Gao, C. Li,Z. Zhang, GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. (2017).Nucleic Acids Res,W1, W98-W102.http://dx.doi.org/10.1093/nar/gkx247
J. Ru, P. Li, J. Wang, W. Zhou, B. Li, C. Huang, P. Li, Z. Guo, W. Tao, Y. Yang, X. Xu, Y. Li, Y. Wang,L. Yang, TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. (2014).J Cheminform,13.http://dx.doi.org/10.1186/1758-2946-6-13
A. wanli,Y. hong, Analysis on the regularity of prescription of traditional Chinese medicine for the treatment of prostate cancer. (2018).Pharmacovigilance in China,03, 158-162.http://dx.doi.org/
O. Trott,A. J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. (2010).J Comput Chem,2, 455-61.http://dx.doi.org/10.1002/jcc.21334
G. Lagger, D. O’Carroll, M. Rembold, H. Khier, J. Tischler, G. Weitzer, B. Schuettengruber, C. Hauser, R. Brunmeir, T. Jenuwein,C. Seiser, Essential function of histone deacetylase 1 in proliferation control and CDK inhibitor repression. (2002).Embo j,11, 2672-81.http://dx.doi.org/10.1093/emboj/21.11.2672
H. Ma, H. Chen, X. Guo, Z. Wang, M. E. Sowa, L. Zheng, S. Hu, P. Zeng, R. Guo, J. Diao, F. Lan, J. W. Harper, Y. G. Shi, Y. Xu,Y. Shi, M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability. (2012).Proc Natl Acad Sci U S A,13, 4828-33.http://dx.doi.org/10.1073/pnas.1116349109
Y. Liu, G. Liang, T. Zhou,Z. Liu, Silencing UHRF1 Inhibits Cell Proliferation and Promotes Cell Apoptosis in Retinoblastoma Via the PI3K/Akt Signalling Pathway. (2020).Pathol Oncol Res,2, 1079-1088.http://dx.doi.org/10.1007/s12253-019-00656-7
X. Kong, J. Chen, W. Xie, S. M. Brown, Y. Cai, K. Wu, D. Fan, Y. Nie, S. Yegnasubramanian, R. L. Tiedemann, Y. Tao, R. W. Chiu Yen, M. J. Topper, C. A. Zahnow, H. Easwaran, S. B. Rothbart, L. Xia,S. B. Baylin, Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties. (2019a).Cancer Cell,4, 633-648 e7.http://dx.doi.org/10.1016/j.ccell.2019.03.003
W. Zhang,J. Xu, DNA methyltransferases and their roles in tumorigenesis. (2017).Biomark Res,1.http://dx.doi.org/10.1186/s40364-017-0081-z
A. Scott, F. Bai, H. L. Chan, S. Liu, J. M. Slingerland, D. J. Robbins, A. J. Capobianco,X. H. Pei, p16 loss rescues functional decline of Brca1-deficient mammary stem cells. (2017).Cell Cycle,8, 759-764.http://dx.doi.org/10.1080/15384101.2017.1295185
H. Chen, X. Liu, W. Zhu, H. Chen, X. Hu, Z. Jiang, Y. Xu, L. Wang, Y. Zhou, P. Chen, N. Zhang, D. Hu, L. Zhang, Y. Wang, Q. Xu, R. Wu, H. Yu,J. Wang, SIRT1 ameliorates age-related senescence of mesenchymal stem cells via modulating telomere shelterin. (2014).Front Aging Neurosci,103.http://dx.doi.org/10.3389/fnagi.2014.00103
A. Sharma, A. K. Verma, M. Kofron, R. Kudira, A. Miethke, T. Wu, J. Wang,C. R. Gandhi, Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors. (2020).Hepatology,5, 1800-1818.http://dx.doi.org/10.1002/hep.31188
D. Hanahan,R. A. Weinberg, Hallmarks of cancer: the next generation. (2011).Cell,5, 646-74.http://dx.doi.org/10.1016/j.cell.2011.02.013
M. Yamashita, K. Inoue, N. Saeki, M. Ideta-Otsuka, Y. Yanagihara, Y. Sawada, I. Sakakibara, J. Lee, K. Ichikawa, Y. Kamei, T. Iimura, K. Igarashi, Y. Takada,Y. Imai, Uhrf1 is indispensable for normal limb growth by regulating chondrocyte differentiation through specific gene expression. (2018).Development,1, 10.1242/dev.157412
M. Mancini, E. Magnani, F. Macchi,I. M. Bonapace, The multi-functionality of UHRF1: epigenome maintenance and preservation of genome integrity. (2021).Nucleic Acids Res,11, 6053-6068.http://dx.doi.org/10.1093/nar/gkab293
W. Ashraf, A. Ibrahim, M. Alhosin, L. Zaayter, K. Ouararhni, C. Papin, T. Ahmad, A. Hamiche, Y. Mély, C. Bronner,M. Mousli, The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer. (2017).Oncotarget,31, 51946-51962.http://dx.doi.org/10.18632/oncotarget.17393
X. Kong, J. Chen, W. Xie, S. M. Brown, Y. Cai, K. Wu, D. Fan, Y. Nie, S. Yegnasubramanian, R. L. Tiedemann, Y. Tao, R. W. Chiu Yen, M. J. Topper, C. A. Zahnow, H. Easwaran, S. B. Rothbart, L. Xia,S. B. Baylin, Defining UHRF1 Domains that Support Maintenance of Human Colon Cancer DNA Methylation and Oncogenic Properties. (2019b).Cancer Cell,4, 633-648.e7.http://dx.doi.org/10.1016/j.ccell.2019.03.003
M. Felle, S. Joppien, A. Nemeth, S. Diermeier, V. Thalhammer, T. Dobner, E. Kremmer, R. Kappler,G. Langst, The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1. (2011).Nucleic Acids Res,19, 8355-65.http://dx.doi.org/10.1093/nar/gkr528
A. P. Turnbull, S. Ioannidis, W. W. Krajewski, A. Pinto-Fernandez, C. Heride, A. C. L. Martin, L. M. Tonkin, E. C. Townsend, S. M. Buker, D. R. Lancia, J. A. Caravella, A. V. Toms, T. M. Charlton, J. Lahdenranta, E. Wilker, B. C. Follows, N. J. Evans, L. Stead, C. Alli, V. V. Zarayskiy, A. C. Talbot, A. J. Buckmelter, M. Wang, C. L. McKinnon, F. Saab, J. F. McGouran, H. Century, M. Gersch, M. S. Pittman, C. G. Marshall, T. M. Raynham, M. Simcox, L. M. D. Stewart, S. B. McLoughlin, J. A. Escobedo, K. W. Bair, C. J. Dinsmore, T. R. Hammonds, S. Kim, S. Urbe, M. J. Clague, B. M. Kessler,D. Komander, Molecular basis of USP7 inhibition by selective small-molecule inhibitors. (2017).Nature,7677, 481-486.http://dx.doi.org/10.1038/nature24451